Trial Profile
Levosimendan como agente inmunomodulador en la insuficiencia cardiaca aguda. Estudio Piloto Levosimendan as an immunomodulatory agent in acute heart failure. Pilot study.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2011
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Decompensated heart failure
- Focus Biomarker; Pharmacodynamics
- 30 Aug 2011 New trial record